Neuralink Receives FDA Go-Ahead for First Human Trials

Neuralink has received FDA approval to conduct its first human trials, indicating its potential to revolutionize the lives of individuals with neurological conditions and disabilities.

Neuralink's ambitious goal is to create a seamless connection between human brains and computers, enabling individuals to communicate and interact with machines in unprecedented ways.

In a groundbreaking development for the field of neurotechnology, Neuralink, the brain-machine interface company founded by ...

Subscribe to view this content.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].